Imaging glucose metabolism in perfluorocarbon-perfused hepatocyte bioreactors using positron emission tomography

Journal of Artificial Organs

Volumn 12, Issue 4, 2009, Pages 247-257

  Nieuwoudt, Martin ^a   Wiggett, Scholtz ^b   Malfeld, Susan ^a   Van Der Merwe, Schalk W ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Steve Biko Academic Hospital   (South Africa)

Author keywords

Bioartificial liver; Hepatocyte bioreactor; Perfluorocarbon; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LACTIC ACID; OXYGEN; FLUOROCARBON; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

AMBIENT AIR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CELL FREE SYSTEM; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; GAS; GLUCOSE METABOLISM; HUMAN; HYPOXIC CELL; IN VITRO STUDY; LIVER CELL; LIVER FAILURE; NONHUMAN; OXYGENATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; STEADY STATE; STELLATE CELL; ANIMAL; ARTIFICIAL LIVER; CHEMISTRY; DRUG EFFECT; METABOLISM; SWINE;

ANIMALS; BIOREACTORS; COCULTURE TECHNIQUES; FLUOROCARBONS; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEPATIC STELLATE CELLS; HEPATOCYTES; LIVER, ARTIFICIAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SWINE;

EID: 77949910625     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-009-0480-5     Document Type: Article

References (55)

1. Nahmias Y, Berthiaume F, Yarmush ML. Integration of technologies for hepatic tissue engineering. Adv Biochem Eng Biotechnol 2006;103:309-329
2. Arias IM, Boyer JL, Chisary FV, Fausto N, Jakoby WB, Schachter D, Shafritz DA (eds). The liver: biology and pathobiology. Philadelphia: Lippincott, Williams, and Wilkins, 2001;3
3. Jundermann K, Kietzmann T. Zonation of parenchymal and non-parenchymal metabolism in liver. Annu Rev Nutrit 1996;16: 179-260
4. Jundermann K, Thurman RG. Hepatocyte heterogeneity in the metabolism of carbohydrates. Enzyme 1992;46:33-58
5. Lindros KO. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol 1997;28:191-196
6. Allen JW, Bhatia SN. Formation of steady-state oxygen gradients in vitro. Biotechnol Bioeng 2003;82(3):253-362
7. Nishikawa M, Uchino J, Matsushita M, Takahashi M, Taguchi K, Koike M, Kamachi H, Kon H. Optimal oxygen tension conditions for functioning cultured hepatocytes in vitro. Artif Organs 1996; 20(2):169-177
8. Rotem A, Toner M, Bhatia S, Foy BD, Tompkins RG, Yarmush ML. Oxygen is a factor determining in vitro tissue assembly: effects on attachment and spreading of hepatocytes. Biotech Bioeng 1994;43:654-660
9. Wolfe D, Schmidt H, Jungermann K. Short-term modulation of glycogen metabolism, glycolysis and gluconeogenesis by physiological oxygen concentrations in hepatocyte cultures. Eur J Biochem 1983;135:405-412
10. Wolfe D, Jundermann K. Long-term effects of physiological oxygen concentrations on glycolysis and gluconeogenesis in hepatocyte cultures. Eur J Biochem 1985;151:299-303
11. Ohno K, Maier P. Cultured rat hepatocytes adapt their cellular glycolytic activity and adenylate energy status to tissue oxygen tension. J Cellular Physiol 1994;160:358-366
12. Allen JW, Khetani SR, Bhatia SN. In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci 2005;84:110-119
13. Sivaraman A, Laech JK, Townsend S, Iida T, Hogan BJ, Stolz DB, Fry R, Samson LD, Tannenbaum SR, Griffith LG. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 2005;6:569-591
14. Allen JW, Bhatia SN. Improving the next generation of bioArtificial livers. Cell Develop Biol 2002;13:447-454
15. Riccalton-Banks L, Liew C, Bhandari R, Fry J, Shakesheff K. Long-term culture of functional liver tissue: 3-D coculture of primary hepatocytes and stellate cells. Tissue Eng 2003;9(3): 401-410
16. Watanabe T, Shibata N, Westerman KA, Okitsu T, Kobayashi N. Establishment of immortalized human hepatic stellate scavenger cells to develop bioArtificial livers. Transplantation 2003;75:1873-1880 (Pubitemid 36734645)
17. Morin O, Normand C. Long-term maintenance of hepatocyte functional activity in co-culture. J Cell Physiol 1986;129:103-110
18. Okamoto M, Ishida Y, Keogh A, Strain A. Evaluation of the function of primary human hepatocytes co-cultured with the human hepatic stellate cell (HSC) line L190. Int J Artif Org 1998;6: 353-359
19. Lowe KC, Davey MR, Power JB. Perfl uorochemicals: their applications and benefi ts to cell culture. Trends Biotechnol 1998;16: 272-277
20. King AT, Mulligan BJ, Lowe KC. Review: perfl uorochemicals and cell culture. Biotechnology 1989;7:1037-1042
21. Lowe KC, Anthony P, Wardrop J, Davey MR, Power JB. Perfl uorochemicals and cell biotechnology. Artif Cells Blood Substit Immobil Biotechnol 1997;25(3):261-274
22. Lowe KC. Review. Engineering blood: synthetic substitutes from fluorinated compounds. Tissue Eng 2003;9(3):389-399
23. Niu M, Clemens MG, Coger RN. Optimizing normoxic conditions in liver devices using enhanced gel matrices. Biotechnol Bioeng 2007;99(6):1502-1512
24. Khattak SF, Chin K, Bhatia SR, Roberts SC. Enhancing O2 tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng 2007;96(1): 156-166
25. Ju LK, Lee JF, Armiger WB. Enhancing oxygen transfer in bioreactors by perfluorocarbon emulsions. Biotechnol Prog 1991;7: 323-329
26. McMillan JD, Wang DIC. Enhanced oxygen transfer using oil-inwater dispersions. Ann New York Acad Sci 1987;506:569-582
27. Elibol M, Mavituna F. Effect of perfl uorodecalin as an oxygen carrier on actinorhodin production by Streptomyces coelicor. Appl Microbiol Biotechnol 1995;43:206-210
28. Kinasiewicz A, Smietanka A, Gajkowska B, Werynski A. Impact of oxygenation of bioArtificial liver using perfluorocarbon emulsion Perftoran on metabolism of human hepatoma C3A cells. Artif Cells Blood Substit Immobil Biotechnol 2008;36:525-534
29. Nieuwoudt M, Moolman S, Van Wyk AJ, Kreft E, Olivier B, Laurens JB, Stegman F, Vosloo J, Bond R, van der Merwe SW. Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier. Artif Organs 2005;29(11):915-918
30. Hoekstra R, Chamuleau RAFM. Recent developments on human cell lines for the bio-Artificial liver. Int J Artif Org 2002;25(3): 182-191
31. Moolman FS, Rolfes H, van der Merwe SW, Focke WW. Optimization of perfluorocarbon emulsion properties for enhancing oxygen mass transfer in a bio-Artificial liver support system. Biochem Eng J 2004;19:237-250
32. Moolman FS. Oxygen carriers for a novel bio-Artificial liver support system. PhD Thesis, University of Pretoria, 2004, available at http://upetd.up.ac.za/thesis/available/etd-09092004-162043/
33. Nieuwoudt MJ, Kreft E, Olivier B, Malfeld S, Vosloo J, Stegman F, van der Merwe SW. A large-scale automated method for hepatocyte isolation: effects on proliferation in culture. Cell Transplant 2005;14(5):291-299
34. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, Howard TA, Michalopolous GK. Population expansion, clonal growth and specific differentiation patterns in primary cultures induced by HGF/SF, EGF and TDF in a chemically defi ned (HGM) medium. J Cell Biology 1996;132(6):1133-1149
35. Runge DM, Runge D, Dorko K, Pisarov LA, Leckel K, Kostrubsky VE, Thomas D, Strom SC, Michalopoulos GK. EGF and HGF activity in serum-free cultures of human hepatocytes. J Hepatol 1999;30:265-274
36. Su T, Waxman D. Impact of DMSO and expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes. Arch Biochem Biophys 2004;424:226-234
37. Powers MJ, Janigian DM, Wack KE, Baker CS, Stolz DB, Griffith LG. Functional behaviour of primary rat liver cells in a 3D perfused microarray bioreactor. Tissue Eng 2002;8(3):499-513
38. Jasmund I, Schwientek S, Acikgoz A, Langsch A, Machens HG, Bader A. The influence of medium composition and matrix on long-term cultivation of primary porcine and human hepatocytes. Biomol Eng 2007;24:59-69
39. Rago R, Mitchen J, Wilding G. DNA fl uorometric assay in 96-well culture plates using Hoechst 33258. Anal Biochem 1990;191: 31-34
40. Nyberg SL, Shatford RA, Payne WD, Hu WS, Cerra FB. Staining with fluorescein diacetate correlates with hepatocyte function. Biotech Histochem 1993;68(1):56-62
41. Faultsch H, Zobeley S, Rinnerthaler G, Small JV. Fluorescent phallotoxins for filamentous actin. J Muscle Res Cell Motil 1988; 9:370-383
42. Smith MD, Smirthwaite AD, Cairns DE, Cousins RB, Gaylor JD. Techniques for measurement of oxygen consumption rates of hepatocytes during attachment and post-attachment. Int J Artif Org 1996;19(1):36-44
43. Sullivan J, Harris DR, Palmer AF. Convection and hemoglobinbased O2 carrier enhanced transport in a HF bioreactor. Artif Cells Blood Substit Immobil Biotechnol 2008;36:386-402
44. Mareels G, Poyck P, Elloot S, Chamuleau R, Verdonck P. Numerical simulation of fl uid flow and oxygen transport in a full-scale model of the AMC bioArtificial liver with an in vitro determined hepatocyte distribution. Ann Biomed Eng 2006 34(11):1729-1744
45. Ronné LJT. Design considerations and analysis of a bioreactor for application in a bioArtificial liver support system. Masters dissertation, University of Pretoria, 2007
46. Freire MG, Dias AMA, Coutinho JAP, Coelho MAZ, Marrucho IM. Enzymatic method for determining O2 solubility in perfluorocarbon emulsions. Fluid Phase Equil 2005;231:109-113
47. Martin Y, Vermette P. Bioreactors for tissue mass culture: design, characterization and recent advances. Biomaterials 2005;26: 7481-7503
48. Heath CA, Hammer BE, Pimbley JM. Magnetic resonance imaging of flow in HF bioreactors. AIChE J 1990;36(4):547-558
49. Donoghue C, Brideau M, Newcomer P, Pangrle B, DiBasio D, Walsh E, Moore S. Use of MRI to analyse the performance of HF bioreactors. Ann NY Acad Sci 1992;665:285-300
50. Planchamp C, Ivancevic MK, Pastor CM, Vallée JP, Pochon S, Terrier F, Mayer JM, Reist M. Hollow fi ber bioreactor: new development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging. Biotechnol Bioeng 2004;85(6): 656-665
51. Ferreira EC, Mota M, Pons MN. Image analysis and multiphase bioreactors. In: Multiphase bioreactor design. Cabral JMS, Mota M, Tramper J (eds) London: Taylor and Francis, 2001;25-52
52. Kofidis T, Lenz A, Boublik J, Akhyari P, Wachsmann B, Stahl KM, Haverich A, Leyh RG. BioArtificial grafts for transmural myocardial restoration: a new cardiovascular tissue culture concept. Eur J Cardiothorac Surg 2003;24:906-911
53. Kofidis T, Lenz A, Boublik J, Akhyari P, Wachsmann B, Stahl KM, Hofmann M, Haverich A. Pulsatile perfusion and cardiomyocyte viability in a solid 3D matrix. Biomaterials 2003;24:5009-5014
54. Walles T, Giere B, Hofmann M, Schanz J, Hofmann F, Mertsching H, Macchiarini P. Experimental generation of a tissue-engineered functional and vascularized trachea. Gen Thorac Surg 2004;129(6): 900-906
55. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. PNAS 2000;97(16):9226-9233